業績｜論文・出版物｜目次｜

2020

Tolloid-like 1 negatively regulates hepatic differentiation of human iPS cells through transforming growth factor beta signaling

Kiso A., Toba Y., Tsutsumi S., Deguchi S., Igai K., Koshino S., Tanaka Y., Takayama K., Mizuguchi H.

Hepatol. Commun., 4, 255-267 (2020)

Click

(外部サイトへリンク)

Photoactivatable oncolytic adenovirus for optogenetic cancer therapy

Hagihara Y., Sakamoto A., Tokuda T., Yamashita T., Ikemoto S., Kimura A., Haruta M., Sasagawa K., Ohta J., Takayama K., Mizuguchi H.

Cell Death Dis., 11, 570 (2020)

Click

(外部サイトへリンク)

Establishment of MDR1-knockout human induced pluripotent stem cell line

Negoro R., Kawai K., Ichikawa M., Deguchi S., Takayama K., Mizuguchi H.

Drug Metab. Pharmacokinet., 35, 288-296 (2020)

Click

(外部サイトへリンク)

Oncolytic Virus-Mediated Targeting of the ERK Signaling Pathway Inhibits Invasive Propensity in Human Pancreatic Cancer

Koujima T., Tazawa H., Ieda T., Araki H., Fushimi T., Shoji R., Kuroda S., Kikuchi S., Yoshida R., Umeda Y., Teraishi F., Urata Y., Mizuguchi H., Fujiwara T.

Mol. Ther. Oncolytics, 17, 107-117 (2020)

Click

(外部サイトへリンク)

Comparison of commercially available media for hepatic differentiation and hepatocyte maintenance

Toba Y., Deguchi S., Mimura N., Sakamoto A., Harada K., Hirata K., Takayama K., Mizuguchi H.

PLoS One, 15, e0229654 (2020)

Click

(外部サイトへリンク)

Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 Antibody

Kanaya N., Kuroda S., Kakiuchi Y., Kumon K., Tsumura T., Hashimoto M., Morihiro T., Kubota T., Aoyama K., Kikuchi S., Nishizaki M., Kagawa S., Tazawa H., Mizuguchi H., Urata Y., Fujiwara T.

Mol. Ther., 28, 794-804 (2020)

Click

(外部サイトへリンク)

Development of a Novel Oncolytic Adenovirus Expressing a Short-hairpin RNA Against Cullin 4A

Wakabayashi K., Sakurai F., Ono R., Fujiwara T., Mizuguchi H.

Anticancer Res., 40, 161-168 (2020)

Click

(外部サイトへリンク)

Ablation of IL-17A leads to severe colitis in IL-10-deficient mice: implications of myeloid-derived suppressor cells and NO production

Tachibana M., Watanabe N., Koda Y., Oya Y., Kaminuma O., Katayama K., Fan Z., Sakurai F., Kawabata K., Hiroi T., Mizuguchi H.

Int. Immunol., 32, 187-201 (2020)

Click

(外部サイトへリンク)

Generation of human induced pluripotent stem cell-derived hepatocyte-like cells for cellular medicine

Deguchi S., Takayama K., Mizuguchi H.

Biol. Pharm. Bull., 43, 608-615 (2020)

Click

(外部サイトへリンク)

Aspects of gene therapy products using current genome-editing technology in Japan

Yamaguchi T., Uchida E., Okada T., Ozawa K., Onodera M., Kume A., Shimada T., Takahashi S., Tani K., Nasu Y., Mashimo T., Mizuguchi H., Mitani K., Maki K.

Hum. Gene Ther., 31, 1043-1053 (2020)

Click